Citation Impact
Citing Papers
An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice
2012
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
2007 Standout
The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring
2016 StandoutScience
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Obesity alters gut microbial ecology
2005 Standout
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites
2015
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
Small intestinal transit in patients with liver cirrhosis and portal hypertension: a descriptive study
2012
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis
1999
Cadaver Donor Screening for Infectious Agents in Solid Organ Transplantation
2000
Hepatocellular carcinoma
2003 Standout
Hepatitis C Virus–Specific CD4+T Cell Response after Liver Transplantation Occurs Early, Is Multispecific, Compartmentalizes to the Liver, and Does Not Correlate with Recurrent Disease
2001 StandoutNobel
α1-antitrypsin deficiency
2005
Cancer incidence in a kidney-transplanted population
2000
Liver fibrosis
2005 Standout
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Fatal Autoimmune Hepatitis Induced by Concurrent Loss of Naturally Arising Regulatory T Cells and PD-1-Mediated Signaling
2008 StandoutNobel
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Epidemiology of Severe Hospital‐Acquired Infections in Patients with Liver Cirrhosis: Effect of Long‐Term Administration of Norfloxacin
1998
Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis
2010
Human Genetics Shape the Gut Microbiome
2014 Standout
Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death
2004
Hepatitis B and Hepatitis C Viruses in Liver Transplantation
2004
Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality
1998
The Transjugular Intrahepatic Portosystemic Stent–Shunt Procedure for Refractory Ascites
1995
Spontaneous bacterial peritonitis: recent guidelines and beyond
2011
Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients
2000
Small bowel bacterial overgrowth in patients with alcoholic cirrhosis
1996
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites
2013
Hepatitis C Infection in Liver Transplantation
2001
Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model
2014
The Course of Posttransplant Hepatitis C Infection
2012
Pathological bacterial translocation in liver cirrhosis
2013
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†
1996
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
2020
Therapeutic Potential of Fecal Microbiota Transplantation
2013
Alterations in intestinal microbial flora and human disease
2008
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis
2000
HIV-1 Vpr Triggers Natural Killer Cell–Mediated Lysis of Infected Cells through Activation of the ATR-Mediated DNA Damage Response
2009
Liver Transplantation With Older Donors
2016
Non-alcoholic fatty liver disease
2021 Standout
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
2019 Standout
The role of the gut microbiota in NAFLD
2016
A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with Ascites
2000
Management of Cirrhosis and Ascites
2004
Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients
2005
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Adenosine A2Areceptors play a role in the pathogenesis of hepatic cirrhosis
2006
Intestinal barrier dysfunction in developing liver cirrhosis: An in vivo analysis of bacterial translocation
2007
Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease
2009
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
2015
The North American Study for the Treatment of Refractory Ascites
2003
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
Current understanding of the human microbiome
2018 Standout
Management of adult patients with ascites caused by cirrhosis†
1998
Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis
2000
A prognostic model for predicting survival in cirrhosis with ascites
2001
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Paradoxical roles of the immune system during cancer development
2006 Standout
Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost
2005
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
2000 Standout
Mechanisms of hepatitis B virus graft reinfection and graft damage after liver transplantation
2004
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Autoimmune hepatitis: evolving concepts
2004
Intestinal bacterial translocation in rats with cirrhosis is related to compromised paneth cell antimicrobial host defense
2011
Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial
1996
Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: A systematic review and cumulative meta-analysis
2015
Infection in Solid-Organ Transplant Recipients
2007 Standout
Deciphering the role of Th17 cells in human disease
2011
Recurrent Disease Following Liver Transplantation for Nonalcoholic Steatohepatitis Cirrhosis
2009
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
2007 Standout
External validation of a prognostic model for predicting survival of cirrhotic patients with refractory ascites1
2002
Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trials of spironolactone versus placebo
1997
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis
2002
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
Autophagy in immunity and inflammation
2011 StandoutNature
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
2014 Standout
Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management
2003
Gut microbiota-related complications in cirrhosis
2014
Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis
2002
Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation
2015
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Gut Microbiota in Health and Disease
2010 Standout
Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study
2000
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males
2007 StandoutNobel
IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
2012
Dialogue between E. coli free radical pathways and the mitochondria of C. elegans
2015 StandoutNobel
Microbial Translocation in Chronic Liver Diseases
2012
Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death
2004
Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene
2001 StandoutNobel
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene
2004 StandoutNobel
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
Metagenomics of the Human Body
2010
De Novo Neoplasia After Liver Transplantation: An Analysis of Risk Factors and Influence on Survival
2004
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Uncovered Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-Analysis
2005
Portal Hypertension and Its Complications
2008
Hepatitis C and liver transplantation
2001
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Alcoholic Liver Disease: The Gut Microbiome and Liver Cross Talk
2015
Adrenomedullin, a Multifunctional Regulatory Peptide*
2000
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Nonalcoholic Fatty Liver Disease
2015 Standout
Microbial Translocation Across the GI Tract
2012
Gut Microbiota and Host Reaction in Liver Diseases
2015
Effects of alfapump™ system on kidney and circulatory function in patients with cirrhosis and refractory ascites
2017
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Interactions Between Gut Microbiota and Host Metabolism Predisposing to Obesity and Diabetes
2010
Cancer incidence in a kidney-transplanted population
2000
Hepatic toll‐like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD
2014
Works of Fernando Casafont being referenced
Apoptosis mediated by the Fas system in the fulminant hepatitis by hepatitis B virus
2002
Influence of malnutrition on the prevalence of bacterial translocation and spontaneous bacterial peritonitis in experimental cirrhosis in rats
1997
Liver transplantation in hepatitis C. A Spanish multi-centre experience
1998
Liver Transplantation in a Case of Steatohepatitis and Subacute Hepatic Failure after Biliopancreatic Diversion for Morbid Obesity
2001
A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation
2003
Lipopolysaccharide-Binding Protein Plasma Levels and Liver TNF-Alpha Gene Expression in Obese Patients: Evidence for the Potential Role of Endotoxin in the Pathogenesis of Non-Alcoholic Steatohepatitis
2007
Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease
2005
Changes in the Serum Levels of Interleukin-17/Interleukin-23 During Acute Rejection in Liver Transplantation
2009
Involvement of the fas system in hepatitis C virus recurrence after liver transplantation
2000
The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients
2014
Severe clinical course of de novo hepatitis B infection after liver transplantation
1999
Granulocyte Elastase in Cirrhotic Patients with Spontaneous Bacterial Peritonitis
1999
Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis
2005
Liver Transplantation With Donors Older Than 75 Years
2011
Paracentesis with Intravenous Infusion of Albumin as Compared with Peritoneovenous Shunting in Cirrhosis with Refractory Ascites
1991
Natural killer cell activity in alcoholic cirrhosis: influence of nutrition.
1990
Incidence and outcome of De Novo malignancies after liver transplantation
1999
[Development of spontaneous bacterial peritonitis in an experimental model in cirrhotic rats. Relationship with intestinal bacterial translocation].
1995
Plasma adrenomedullin levels in patients with hepatic cirrhosis.
1997
Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomized, multicenter study
1995
Interleukin-2 and natural killer activity in acute type B hepatitis.
1991
Could Alpha1 Antitrypsin Deficiency Have Any Role in the Development of Celiac Sprue After Gastric Operations?
1986
Tuberculous Peritonitis
1990
Tuberculous peritonitis: a study comparing cirrhotic and noncirrhotic patients.
1990